文献速递肝胆胰外科围术期管理与 ERAS

胰腺手术复合终点(PACE)模型的验证与改良:东南亚单中心研究

Validation and modification of the PAncreatic surgery Composite Endpoint (PACE) model: A single-institution study from Southeast Asia.
PubMed 文献 · Surgery · 2025-06-12

该研究在新加坡单中心575例胰腺切除术患者中验证PACE模型,并评估加入胃排空延迟的改良PACE(mPACE)对预测延长住院和90天死亡的作用。结果显示mPACE预测延长住院的AUC为0.781,优于PACE的0.669;两者预测90天死亡的AUC分别为0.679和0.682,性能相当。

要点

  • mPACE预测延长住院的AUC为0.781,优于PACE的0.669。
  • PACE与mPACE预测90天死亡的AUC分别为0.682和0.679,性能相当。
  • 加入胃排空延迟可提升PACE对延长住院的预测性能。

核心结论

  • PACE与mPACE均可用于预测胰腺切除术后延长住院和90天死亡,加入胃排空延迟的mPACE对延长住院预测性能更优。

研究设计与样本

  • 单中心回顾性研究,纳入2018至2023年新加坡中央医院575例胰腺切除术患者。
  • 延长住院定义为住院时间≥20天(住院时间的第75百分位数)。

主要发现

  • 预测延长住院时,mPACE的AUC为0.781,灵敏度79.2%,特异度77.0%;PACE的AUC为0.669,灵敏度53.0%,特异度80.8%。
  • 在胰十二指肠切除术和远端胰腺切除术亚组中,mPACE均显示更强的区分能力且校准良好。
  • 预测术后90天死亡时,PACE与mPACE的AUC分别为0.682和0.679,性能中等且校准良好。

临床怎么用

  • 可将PACE或mPACE作为胰腺切除术后结局的标准化复合终点用于临床监测。
  • mPACE因纳入胃排空延迟,对延长住院的预测更敏感,可优先用于识别高住院风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The PAncreatic surgery Composite Endpoint was developed as a standardized, clinically relevant outcome measure for pancreatectomies, and it has been shown to correlate with prolonged length of stay and 90-day mortality. Although the PAncreatic surgery Composite Endpoint combines key complications of postoperative pancreatic fistula, postpancreatectomy hemorrhage, and reoperation/reintervention into a single measure, delayed gastric emptying has not been integrated. We aimed to validate PAncreatic surgery Composite Endpoint and assess whether adding delayed gastric emptying (modified PAncreatic surgery Composite Endpoint) enhances its predictive performance in a Southeast Asian cohort. METHODS: Prolonged length of stay was defined as ≥20 days (the 75th percentile of length of stay). PAncreatic surgery Composite Endpoint and modified PAncreatic surgery Composite Endpoint were evaluated as binary indicators using logistic regression analyses to assess their associations with prolonged length of stay and 90-day mortality. Model performance was evaluated using the area under the receiver operating characteristic curve, sensitivity, specificity, and calibration curves. RESULTS: A total of 575 patients underwent pancreatectomy at Singapore General Hospital between 2018 and 2023. When predicting prolonged length of stay, modified PAncreatic surgery Composite Endpoint (area under the receiver operating characteristic curve, 0.781; sensitivity, 79.2%; specificity, 77.0%) outperformed PAncreatic surgery Composite Endpoint (area under the receiver operating characteristic curve, 0.669; sensitivity, 53.0%; specificity, 80.8%), demonstrating stronger discrimination in both pancreatoduodenectomy and distal pancreatectomy subcohorts and retaining good calibration. For postoperative 90-day mortality, PAncreatic surgery Composite Endpoint and modified PAncreatic surgery Composite Endpoint demonstrated moderate, comparable performance (area under the receiver operating characteristic curves of 0.682 and 0.679, respectively) and exhibited good calibration. CONCLUSION: The PAncreatic surgery Composite Endpoint and modified PAncreatic surgery Composite Endpoint models are robust and clinically relevant tools for predicting prolonged length of stay and 90-day mortality after pancreatectomy. Adding delayed gastric emptying to the modified PAncreatic surgery Composite Endpoint model enhances its predictive performance for prolonged length of stay.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Tan HL, Zhao Y, Chua DW, et al. Validation and modification of the PAncreatic surgery Composite Endpoint (PACE) model: A single-institution study from Southeast Asia. Surgery. 2025. PMID: 40513210. doi:10.1016/j.surg.2025.109482

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。